First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma
British Journal of Cancer (2016) - Comment
pubmed: 27140316  doi: 10.1038/bjc.2016.120  issn: 0007-0920  issn: 1532-1827 

C Le Tourneau, B Dreno, Y Kirova, J J Grob, T Jouary, C Dutriaux, L Thomas, C Lebbé, L Mortier, P Saiag, M F Avril, E Maubec, P Joly, P Bey, J M Cosset, J S Sun, B Asselain, F Devun, M E Marty, M Dutreix